245 related articles for article (PubMed ID: 16330935)
1. The immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases.
Winstanley AM; Landon G; Berney D; Minhas S; Fisher C; Parkinson MC
Am J Surg Pathol; 2006 Jan; 30(1):1-6. PubMed ID: 16330935
[TBL] [Abstract][Full Text] [Related]
2. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
3. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
Tot T
Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
[TBL] [Abstract][Full Text] [Related]
4. The value of 'mesothelium-associated' antibodies in distinguishing between metastatic renal cell carcinomas and mesotheliomas.
Osborn M; Pelling N; Walker MM; Fisher C; Nicholson AG
Histopathology; 2002 Oct; 41(4):301-7. PubMed ID: 12383211
[TBL] [Abstract][Full Text] [Related]
5. Mesothelioma of the tunica vaginalis testis with prominent adenomatoid features: a case report.
Yang LH; Yu JH; Xu HT; Lin XY; Liu Y; Miao Y; Wang L; Fan CF; Jiang GY; Ding SL; Li G; Wang EH
Int J Clin Exp Pathol; 2014; 7(10):7082-7. PubMed ID: 25400801
[TBL] [Abstract][Full Text] [Related]
6. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
[TBL] [Abstract][Full Text] [Related]
7. Mesothelioma of the tunica vaginalis: a series of eight cases with uncertain malignant potential.
Brimo F; Illei PB; Epstein JI
Mod Pathol; 2010 Aug; 23(8):1165-72. PubMed ID: 20526287
[TBL] [Abstract][Full Text] [Related]
8. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical profile of paratesticular serous papillary adenocarcinoma and tunica vaginalis facilitates distinction from malignant mesothelioma.
Anchala PR; Dhir R; Parwani AV; Zynger DL
Int J Surg Pathol; 2011 Oct; 19(5):692-8. PubMed ID: 19493919
[TBL] [Abstract][Full Text] [Related]
10. Expression of mesothelial markers in malignant mesotheliomas: an immunohistochemical evaluation of 173 cases.
Soomro IN; Oliveira R; Ronan J; Chaudry ZR; Johnson J
J Pak Med Assoc; 2005 May; 55(5):205-9. PubMed ID: 15960287
[TBL] [Abstract][Full Text] [Related]
11. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F
Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647
[TBL] [Abstract][Full Text] [Related]
12. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis.
Chekol SS; Sun CC
Arch Pathol Lab Med; 2012 Jan; 136(1):113-7. PubMed ID: 22208496
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Metastases From Malignant Mesothelioma of the Tunica Vaginalis Testis.
Hispán P; Pascual JC; González I; Bravo D; Peiró G
Am J Dermatopathol; 2016 Mar; 38(3):222-5. PubMed ID: 26894775
[TBL] [Abstract][Full Text] [Related]
14. Comparison of monoclonal versus polyclonal calretinin antibodies for immunohistochemical diagnosis of malignant mesothelioma.
Granville LA; Younes M; Churg A; Roggli VL; Henderson DW; Cagle PT
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):75-9. PubMed ID: 15722797
[TBL] [Abstract][Full Text] [Related]
15. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females.
Shanks JH; Harris M; Banerjee SS; Eyden BP; Joglekar VM; Nicol A; Hasleton PS; Nicholson AG
Am J Surg Pathol; 2000 Feb; 24(2):285-94. PubMed ID: 10680897
[TBL] [Abstract][Full Text] [Related]
16. Malignant mesothelioma of the tunica vaginalis testis: a case with a predominant sarcomatous component.
Shimada S; Ono K; Suzuki Y; Mori N
Pathol Int; 2004 Dec; 54(12):930-4. PubMed ID: 15598316
[TBL] [Abstract][Full Text] [Related]
17. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 2003 Aug; 27(8):1031-51. PubMed ID: 12883236
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
Ordóñez NG
Hum Pathol; 2004 Jun; 35(6):697-710. PubMed ID: 15188136
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity.
Yaziji H; Battifora H; Barry TS; Hwang HC; Bacchi CE; McIntosh MW; Kussick SJ; Gown AM
Mod Pathol; 2006 Apr; 19(4):514-23. PubMed ID: 16554731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
